How Allgenesis Evaluated Unique Endpoints to Advance its Phase

August 11, 2024
Voxeleron

Allgenesis discuss their collaboration on a recent phase two study for diabetic macular edema (DME). The panelists highlight the importance of imaging and biomarkers in ophthalmology clinical trials and share their experiences working with Voxeleron's AI technology. Featuring: Tan Nguyen:…

How Interoperability Drives Ophthalmic Clinical Trial Success for Voiant

August 11, 2024
Voxeleron

Jason Slakter, MD and Hanna Coleman, MD of Voiant Clinical discuss how the unique interoperability of Voxeleron’s Orion platform helps drive ophthalmic clinical trial success. Want to learn more about Orion? Request a demo today or check out voxeleron.com/orion.